Molecular Imaging of Interstitial Lung Disease with Maraciclatide: PREDICT-ILD Data Presented at ERS

Serac Healthcare and the University of Exeter, today announce the first findings from a study evaluating a novel molecular imaging agent, ^99mTc-maraciclatide, as an imaging marker for interstitial lung disease evaluation. The data will be presented at the European Respiratory Society conference taking place from 27 September to 1 October in Amsterdam.